AstraZeneca plc 15.5% Potential Decrease Indicated by UBS

Broker Ratings

AstraZeneca plc with EPIC/TICKER (LON:AZN) has had its stock rating noted as ‘Unchanged’ with the recommendation being set at ‘SELL’ today by analysts at UBS. AstraZeneca plc are listed in the Health Care sector within UK Main Market. UBS have set their target price at 7300 GBX on its stock. This would imply the analyst believes there is a potential downside of -15.5% from today’s opening price of 8635 GBX. Over the last 30 and 90 trading days the company share price has increased 123 points and increased 1250 points respectively. The 52 week high for the stock is 9335 GBX while the year low share price is currently 5871 GBX.

AstraZeneca plc has a 50 day moving average of 8,228.52 GBX and the 200 Day Moving Average price is recorded at 7,605.31. There are currently 1,312,261,399 shares in issue with the average daily volume traded being 2,396,933. Market capitalisation for LON:AZN is £114,744,136,728 GBP.

You might also enjoy reading  Astrazeneca PLC - Consensus Indicates Potential 12.2% Upside
Find more news, interviews, share price & company profile here for:

    Good news travels fast (but only if you make that happen). Share on:


      AIM All Share Index